Share Price and Basic Stock Data
Last Updated: October 18, 2025, 5:08 pm
| PEG Ratio | 8.60 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Galaxy Surfactants Ltd operates in the oil drilling and exploration sector, with its stock currently priced at ₹2,210 and a market capitalization of ₹7,825 Cr. The company’s revenue trajectory has shown significant growth over recent years, with sales rising from ₹3,684 Cr in FY 2022 to ₹4,462 Cr in FY 2023. However, the latest quarterly figures indicate a decline in sales, recorded at ₹929 Cr for Mar 2024, with a slight recovery to ₹1,278 Cr anticipated by Jun 2025. The company’s operating profit margin (OPM) stood at 10% in the latest reporting period, reflecting a consistent performance relative to earlier periods. Notably, the company’s sales growth has been driven by a strong demand for surfactants, which are essential in various industries, including personal care and home care. The overall demand environment seems robust, although recent fluctuations in quarterly sales suggest potential challenges in maintaining this growth trajectory amid market volatility.
Profitability and Efficiency Metrics
Galaxy Surfactants has demonstrated solid profitability metrics, with a reported net profit of ₹305 Cr for FY 2025, translating to an earnings per share (EPS) of ₹86.00. The company’s return on equity (ROE) was reported at 13.5%, while return on capital employed (ROCE) stood at 16.2%, indicating effective utilization of shareholder funds and capital. The interest coverage ratio (ICR) is notably high at 22.22x, suggesting that the company is well-equipped to meet its interest obligations, which totaled ₹6 Cr in the latest quarter. The cash conversion cycle (CCC) of 73 days reflects a moderate efficiency in managing working capital, although it has slightly increased from previous years, indicating potential room for improvement. Overall, the profitability and efficiency metrics position Galaxy Surfactants favorably within the industry, although maintaining these levels may require continuous operational improvements and market adaptation.
Balance Sheet Strength and Financial Ratios
The balance sheet of Galaxy Surfactants reveals a resilient financial structure, with total assets reported at ₹3,450 Cr and total borrowings of ₹210 Cr, resulting in a low debt-to-equity ratio of 0.06. This indicates a conservative approach to leveraging, which is beneficial in times of economic uncertainty. The company has accumulated reserves of ₹2,327 Cr, providing a substantial buffer for future investments or downturns. Furthermore, liquidity ratios are strong, with a current ratio of 2.82 and a quick ratio of 1.90, showcasing the company’s ability to cover short-term liabilities comfortably. The price-to-book value (P/BV) ratio of 3.69x suggests that the stock may be trading at a premium compared to its book value, which could be justified by its growth prospects and strong financial health. Overall, Galaxy Surfactants’ balance sheet reflects a solid foundation, although the high P/BV may raise some concerns among value-oriented investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Galaxy Surfactants indicates a stable ownership structure, with promoters holding 70.91% of the company as of Mar 2025. This significant stake enhances investor confidence, as it suggests a strong commitment from the founding family. Foreign institutional investors (FIIs) have gradually increased their stake to 4.30%, while domestic institutional investors (DIIs) account for 12.70%, highlighting growing interest from institutional players. The public shareholding stands at 12.09%, with a total of 51,272 shareholders, reflecting a diverse investor base. However, the decline in public shareholding from earlier periods may indicate a consolidation trend among larger investors, which could influence the stock’s liquidity. Overall, the shareholding dynamics suggest a healthy level of institutional interest, although the concentration of promoter ownership may lead to concerns regarding governance and minority shareholder influence.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies are enhanced, Galaxy Surfactants could leverage its strong market position to capitalize on growth opportunities in the surfactants sector. However, risks such as fluctuating raw material prices and potential regulatory changes in the oil drilling and exploration industry could impact profitability. Additionally, the company must navigate competitive pressures from both domestic and international players, which may affect market share. The recent decline in quarterly sales could signal underlying challenges that need to be addressed proactively. Overall, while Galaxy Surfactants is well-positioned financially, its ability to sustain growth and profitability will depend on effective management of these risks and continuous adaptation to market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Galaxy Surfactants Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Natural Resources Ltd | 1,042 Cr. | 81.1 | 83.0/16.2 | 11.9 | 0.00 % | 0.56 % | 2.87 % | 10.0 | |
| Dolphin Offshore Enterprises (India) Ltd | 1,530 Cr. | 382 | 661/200 | 30.4 | 68.1 | 0.00 % | 14.7 % | 18.7 % | 1.00 |
| Deep Energy Resources Ltd | 999 Cr. | 312 | / | 694 | 121 | 0.00 % | 0.39 % | 0.35 % | 10.0 |
| Selan Explorations Technology Ltd | 881 Cr. | 580 | 969/475 | 13.4 | 309 | 0.00 % | 22.8 % | 17.2 % | 10.0 |
| Oil India Ltd | 66,512 Cr. | 409 | 536/322 | 10.1 | 306 | 2.81 % | 12.9 % | 13.3 % | 10.0 |
| Industry Average | 33,135.50 Cr | 439.73 | 90.36 | 566.99 | 0.99% | 10.56% | 9.87% | 6.85 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,159 | 1,232 | 1,085 | 980 | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 |
| Expenses | 1,011 | 1,100 | 931 | 845 | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 |
| Operating Profit | 148 | 132 | 154 | 135 | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 |
| OPM % | 13% | 11% | 14% | 14% | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% |
| Other Income | -2 | 1 | 4 | 7 | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 |
| Interest | 4 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 |
| Depreciation | 19 | 20 | 22 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 |
| Profit before tax | 123 | 107 | 131 | 113 | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 |
| Tax % | 18% | 21% | 19% | 20% | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% |
| Net Profit | 100 | 84 | 106 | 91 | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 |
| EPS in Rs | 28.31 | 23.66 | 29.96 | 25.53 | 21.20 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.40 | 22.42 |
Last Updated: August 20, 2025, 10:40 am
Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,278.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,278.00 Cr., marking an increase of 133.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,154.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,018.00 Cr. (Mar 2025) to 1,154.00 Cr., marking an increase of 136.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to 10.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 20.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 22.42. The value appears strong and on an upward trend. It has increased from 21.40 (Mar 2025) to 22.42, marking an increase of 1.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 5:20 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 4,528 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,044 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 484 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 11% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 32 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 22 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 113 |
| Profit before tax | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 381 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 305 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107.46 | 85.03 | 86.00 | 85.93 |
| Dividend Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 53.73% | 43.69% | 6.76% | 20.89% | 20.42% | 31.30% | -12.91% | 44.87% | -21.00% | 1.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.04% | -36.93% | 14.13% | -0.47% | 10.89% | -44.22% | 57.78% | -65.86% | 22.33% |
Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 4:25 am
Balance Sheet
Last Updated: October 10, 2025, 2:02 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 |
Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 35.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,327.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,144.00 Cr. (Mar 2024) to 2,327.00 Cr., marking an increase of 183.00 Cr..
- For Borrowings, as of Mar 2025, the value is 210.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 187.00 Cr. (Mar 2024) to 210.00 Cr., marking an increase of 23.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 877.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 539.00 Cr. (Mar 2024) to 877.00 Cr., marking an increase of 338.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,450.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,906.00 Cr. (Mar 2024) to 3,450.00 Cr., marking an increase of 544.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,030.00 Cr.. The value appears strong and on an upward trend. It has increased from 973.00 Cr. (Mar 2024) to 1,030.00 Cr., marking an increase of 57.00 Cr..
- For CWIP, as of Mar 2025, the value is 262.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 262.00 Cr., marking an increase of 104.00 Cr..
- For Investments, as of Mar 2025, the value is 299.00 Cr.. The value appears strong and on an upward trend. It has increased from 198.00 Cr. (Mar 2024) to 299.00 Cr., marking an increase of 101.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,859.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,576.00 Cr. (Mar 2024) to 1,859.00 Cr., marking an increase of 283.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,450.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,906.00 Cr. (Mar 2024) to 3,450.00 Cr., marking an increase of 544.00 Cr..
Notably, the Reserves (2,327.00 Cr.) exceed the Borrowings (210.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -261.00 | -176.00 | -122.00 | -60.00 | 55.00 | -27.00 | 160.00 | -20.00 | 241.00 | 275.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 |
| ROCE % | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Balanced Advantage Fund | 53,293,368 | 3.35 | 919.84 | 53,293,368 | 2025-04-22 17:25:35 | 0% |
| SBI Contra Fund | 41,173,788 | 3.01 | 710.66 | 41,173,788 | 2025-04-22 15:56:58 | 0% |
| SBI Long Term Equity Fund | 32,193,555 | 2.77 | 555.66 | 32,193,555 | 2025-04-22 17:25:35 | 0% |
| Quant ELSS Tax Saver Fund | 21,120,000 | 5.04 | 364.53 | 21,120,000 | 2025-04-22 02:17:08 | 0% |
| Franklin India Flexi Cap Fund | 16,373,000 | 2 | 282.6 | 16,373,000 | 2025-04-22 17:25:35 | 0% |
| DSP ELSS Tax Saver Fund | 13,322,785 | 1.66 | 229.95 | 13,322,785 | 2025-04-22 17:25:35 | 0% |
| SBI Arbitrage Opportunities Fund | 10,961,700 | 0.71 | 189.2 | 10,961,700 | 2025-04-22 17:25:35 | 0% |
| SBI Dividend Yield Fund | 10,000,000 | 2.68 | 172.6 | 10,000,000 | 2025-04-22 17:25:35 | 0% |
| DSP Equity Opportunities Fund | 8,922,069 | 1.45 | 153.99 | 8,922,069 | 2025-04-22 17:25:35 | 0% |
| Invesco India Arbitrage Fund | 7,836,975 | 1.07 | 127.04 | 7,836,975 | 2025-04-22 17:25:35 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Diluted EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Cash EPS (Rs.) | 117.14 | 113.20 | 131.02 | 94.17 | 106.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Revenue From Operations / Share (Rs.) | 1191.44 | 1070.35 | 1253.95 | 1039.69 | 785.35 |
| PBDIT / Share (Rs.) | 143.88 | 140.39 | 163.08 | 116.56 | 129.67 |
| PBIT / Share (Rs.) | 112.75 | 112.23 | 139.53 | 96.52 | 108.81 |
| PBT / Share (Rs.) | 107.32 | 105.92 | 133.41 | 92.89 | 105.03 |
| Net Profit / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| NP After MI And SOA / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| PBDIT Margin (%) | 12.07 | 13.11 | 13.00 | 11.21 | 16.51 |
| PBIT Margin (%) | 9.46 | 10.48 | 11.12 | 9.28 | 13.85 |
| PBT Margin (%) | 9.00 | 9.89 | 10.63 | 8.93 | 13.37 |
| Net Profit Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| NP After MI And SOA Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| Return on Networth / Equity (%) | 12.90 | 13.83 | 20.23 | 16.69 | 23.21 |
| Return on Capital Employeed (%) | 16.09 | 17.21 | 24.07 | 19.71 | 26.98 |
| Return On Assets (%) | 8.80 | 10.34 | 13.93 | 10.10 | 14.74 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.14 | 0.23 | 0.18 |
| Asset Turnover Ratio (%) | 1.32 | 1.34 | 1.42 | 1.34 | 1.09 |
| Current Ratio (X) | 2.14 | 2.82 | 2.36 | 1.81 | 1.87 |
| Quick Ratio (X) | 1.40 | 1.90 | 1.41 | 0.99 | 1.18 |
| Inventory Turnover Ratio (X) | 6.60 | 4.15 | 4.30 | 4.78 | 4.19 |
| Dividend Payout Ratio (NP) (%) | 20.93 | 4.70 | 33.50 | 5.39 | 16.42 |
| Dividend Payout Ratio (CP) (%) | 15.36 | 3.53 | 27.48 | 4.24 | 13.19 |
| Earning Retention Ratio (%) | 79.07 | 95.30 | 66.50 | 94.61 | 83.58 |
| Cash Earning Retention Ratio (%) | 84.64 | 96.47 | 72.52 | 95.76 | 86.81 |
| Interest Coverage Ratio (X) | 26.50 | 22.22 | 26.64 | 32.16 | 34.25 |
| Interest Coverage Ratio (Post Tax) (X) | 16.84 | 14.46 | 18.56 | 21.45 | 23.51 |
| Enterprise Value (Cr.) | 7197.68 | 7937.75 | 8295.42 | 10453.78 | 9184.23 |
| EV / Net Operating Revenue (X) | 1.70 | 2.09 | 1.87 | 2.84 | 3.30 |
| EV / EBITDA (X) | 14.11 | 15.95 | 14.35 | 25.30 | 19.98 |
| MarketCap / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| Retention Ratios (%) | 79.06 | 95.29 | 66.49 | 94.60 | 83.57 |
| Price / BV (X) | 3.08 | 3.69 | 4.39 | 6.45 | 6.96 |
| Price / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 117.14. This value is within the healthy range. It has increased from 113.20 (Mar 24) to 117.14, marking an increase of 3.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,191.44. It has increased from 1,070.35 (Mar 24) to 1,191.44, marking an increase of 121.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 143.88. This value is within the healthy range. It has increased from 140.39 (Mar 24) to 143.88, marking an increase of 3.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 112.75. This value is within the healthy range. It has increased from 112.23 (Mar 24) to 112.75, marking an increase of 0.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 107.32. This value is within the healthy range. It has increased from 105.92 (Mar 24) to 107.32, marking an increase of 1.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For PBDIT Margin (%), as of Mar 25, the value is 12.07. This value is within the healthy range. It has decreased from 13.11 (Mar 24) to 12.07, marking a decrease of 1.04.
- For PBIT Margin (%), as of Mar 25, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 9.46, marking a decrease of 1.02.
- For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.00, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 8. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 15. It has decreased from 13.83 (Mar 24) to 12.90, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 17.21 (Mar 24) to 16.09, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 8.80, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.34 (Mar 24) to 1.32, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.82 (Mar 24) to 2.14, marking a decrease of 0.68.
- For Quick Ratio (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.40, marking a decrease of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.15 (Mar 24) to 6.60, marking an increase of 2.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.93. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 20.93, marking an increase of 16.23.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has increased from 3.53 (Mar 24) to 15.36, marking an increase of 11.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.07. This value exceeds the healthy maximum of 70. It has decreased from 95.30 (Mar 24) to 79.07, marking a decrease of 16.23.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has decreased from 96.47 (Mar 24) to 84.64, marking a decrease of 11.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 26.50. This value is within the healthy range. It has increased from 22.22 (Mar 24) to 26.50, marking an increase of 4.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.84. This value is within the healthy range. It has increased from 14.46 (Mar 24) to 16.84, marking an increase of 2.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,197.68. It has decreased from 7,937.75 (Mar 24) to 7,197.68, marking a decrease of 740.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.70, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 15.95 (Mar 24) to 14.11, marking a decrease of 1.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For Retention Ratios (%), as of Mar 25, the value is 79.06. This value exceeds the healthy maximum of 70. It has decreased from 95.29 (Mar 24) to 79.06, marking a decrease of 16.23.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.08, marking a decrease of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
- Net Profit Margin: 7.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.09% (Industry Average ROCE: 10.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.9% (Industry Average ROE: 9.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.8 (Industry average Stock P/E: 90.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gas Transmission/Marketing | GAIL Bhawan 16, Bhikaiji Cama Place, New Delhi Delhi 110066 | shareholders@gail.co.in https://www.gailonline.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep Kumar Gupta | Chairman & Managing Director |
| Mr. Rakesh Kumar Jain | Director - Finance & CFO |
| Mr. Deepak Gupta | Director - Projects |
| Mr. Ayush Gupta | Director - Human Resources |
| Mr. Rajeev Kumar Singhal | Director - Business Development |
| Mr. Sanjay Kumar | Director - Marketing |
| Mr. Akhilesh Jain | Non Official Independent Director |
| Mr. Sanjay Kashyap | Non Official Independent Director |
| Mrs. Kangabam Inaocha Devi | Non Official Independent Director |
| Mr. Yajurvendra Anil Mahajan | Non Official Independent Director |
| Ms. Kamini Chauhan Ratan | Government Nominee Director |
| Mr. Kushagra Mittal | Government Nominee Director |
FAQ
What is the intrinsic value of Galaxy Surfactants Ltd?
Galaxy Surfactants Ltd's intrinsic value (as of 20 October 2025) is 1874.11 which is 15.58% lower the current market price of 2,220.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,871 Cr. market cap, FY2025-2026 high/low of 3,115/2,021, reserves of ₹2,327 Cr, and liabilities of 3,450 Cr.
What is the Market Cap of Galaxy Surfactants Ltd?
The Market Cap of Galaxy Surfactants Ltd is 7,871 Cr..
What is the current Stock Price of Galaxy Surfactants Ltd as on 20 October 2025?
The current stock price of Galaxy Surfactants Ltd as on 20 October 2025 is 2,220.
What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Galaxy Surfactants Ltd stocks is 3,115/2,021.
What is the Stock P/E of Galaxy Surfactants Ltd?
The Stock P/E of Galaxy Surfactants Ltd is 25.8.
What is the Book Value of Galaxy Surfactants Ltd?
The Book Value of Galaxy Surfactants Ltd is 666.
What is the Dividend Yield of Galaxy Surfactants Ltd?
The Dividend Yield of Galaxy Surfactants Ltd is 0.99 %.
What is the ROCE of Galaxy Surfactants Ltd?
The ROCE of Galaxy Surfactants Ltd is 16.2 %.
What is the ROE of Galaxy Surfactants Ltd?
The ROE of Galaxy Surfactants Ltd is 13.5 %.
What is the Face Value of Galaxy Surfactants Ltd?
The Face Value of Galaxy Surfactants Ltd is 10.0.